A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease

Clinical trial NCT07319598 · RECRUITING

Trial details

NCT number: NCT07319598
Sponsor: Peking University Third Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Interstitial Lung Disease (ILD)Connective Tissue Disease-associated Interstitial Lung Disease

Start date: 2023-11-02
Primary completion: 2026-10-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.